Table 5.

Network estimated Relative Risksrelative risks (RRs) of immunosuppressants on total remission.

Supportive Care
1.2 (0.88, 2.4)	Steroids
3.1 (1.2, 9.4)	2.5 (0.74 7.7)	Tacrolimus
1.1 (0.61, 2.6)	0.97 (0.42, 1.7)	0.38 (0.10, 1.30)	Mycophenolate mofetil
0.82 (0.28, 2.9)	0.69 (0.19, 2.0)	0.27 (0.057, 1.30)	0.71 (0.29, 1.8)	Cyclophosphamide
1.4 (0.79, 3.2)	1.2 (0.54, 2.1)	0.46 (0.13, 1.60)	1.2 (0.50, 3.2)	1.7 (0.46, 6.5)	Azathioprine
1.7 (0.20, 13.0)	1.3 (0.14, 11.0)	0.53 (0.055, 5.1)	1.4 (0.14, 12.0)	2.0 (0.17, 20.0)	1.2 (0.12, 9.8)	Cyclophosphamide + Azathioprine

Values are presented as RRs with 95% confidence intervals (CIs). The regimen listed in each row is compared with the regimen listed in each column, and RRs of >1 favor row-defining treatment.